Equities
Health CareMedical Equipment and Services
  • Price (SEK)33.76
  • Today's Change-0.10 / -0.30%
  • Shares traded386.85k
  • 1 Year change-17.34%
  • Beta0.6699
Data delayed at least 15 minutes, as of Jul 01 2025 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arjo AB (publ) is a Sweden-based supplier of products, services and solutions for people with reduced mobility and age-related health challenges. The Company’s offering includes products and solutions within the product segments Patient handling, Hygiene, Disinfection, Therapeutic surfaces, Venous Thromboembolism (VTE) prevention and Diagnostics. Additionally, the Company is offering its customers complementing services. The products comprise ceiling lifts, standing and raising aids, slings, floor lifters, among others. Arjo AB (publ) operates in more than 60 countries, which the Company divides into three geographical areas: North America, Western Europe and Rest of the World.

  • Revenue in SEK (TTM)11.40bn
  • Net income in SEK458.00m
  • Incorporated2016
  • Employees7.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CellaVision AB747.94m152.12m4.34bn228.0028.515.1722.585.806.386.3831.3635.160.74131.957.583,169,233.0015.0814.5917.1217.1068.4868.0520.3419.642.6840.330.026738.496.789.397.997.2533.00--
Surgical Science Sweden AB946.54m141.09m7.81bn336.0055.371.7538.018.252.772.7718.5587.730.19211.687.203,454,507.002.863.913.034.1868.3768.9414.9121.553.25--0.00040.000.139854.17-43.7359.8939.76--
Revenio Group Oyj1.18bn212.87m8.24bn246.0038.686.5830.316.980.71610.71613.974.210.76042.997.06439,489.6013.7814.1115.9217.5371.0470.9618.1220.612.1824.430.101853.127.1915.91-3.2014.6422.935.92
Arjo AB (publ)11.40bn458.00m8.61bn7.00k20.141.185.520.75511.681.6841.8428.780.72844.756.431,588,736.002.923.584.135.4543.5043.974.015.350.68534.620.399744.322.844.823.754.32-12.317.89
Xvivo Perfusion AB854.98m137.00m8.91bn190.0065.434.2639.7410.424.324.3227.0366.430.37591.134.844,499,900.006.023.046.513.2675.0573.7416.0210.863.58--0.01380.0037.6330.0887.52103.4618.21--
RaySearch Laboratories AB (publ)1.27bn223.62m9.59bn422.0051.3912.4622.007.576.526.5236.9326.890.61448.173.143,044,546.0010.852.9616.364.3791.8890.9317.665.801.52217.600.327767.9016.629.96149.4932.190.5132--
Biotage AB1.96bn255.00m11.46bn622.0044.972.9826.335.843.183.1824.4848.050.3981.667.442,913,819.005.188.475.869.9362.6261.6213.0015.071.5624.710.058348.019.8313.3015.458.7430.04--
Data as of Jul 01 2025. Currency figures normalised to Arjo AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

30.27%Per cent of shares held by top holders
HolderShares% Held
Fj�rde AP-fondenas of 31 Dec 202427.07m10.65%
The Vanguard Group, Inc.as of 31 Dec 20248.12m3.20%
Svolder AB (Investment Management)as of 31 Dec 20247.64m3.01%
Dimensional Fund Advisors LPas of 31 Dec 20247.64m3.01%
F�rsta AP-fondenas of 30 Apr 20246.50m2.56%
Lannebo Kapitalf�rvaltning AB (Sweden)as of 31 Mar 20255.24m2.06%
SEB Investment Management ABas of 30 Apr 20243.83m1.51%
BlackRock Fund Advisorsas of 31 Dec 20243.82m1.50%
Handelsbanken Fonder ABas of 31 May 20253.56m1.40%
Holberg Fondsforvaltning ASas of 31 Dec 20243.50m1.38%
More ▼
Data from 29 Feb 2024 - 31 May 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.